Fusion Antibodies, a drug discovery spin-out of Queen’s University Belfast, will be able to further develop its capacity to produce cancer-fighting drugs following support from government agency Invest NI (Northern Ireland).

The agency, which is distributing cash from the European Regional Development Fund, will put £63,304 ($103k) into the firm, of which £22,704 is earmarked for research and development. The rest of the funding will be used to assist the spin-out in setting up the international marketing of its research…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?